154 related articles for article (PubMed ID: 21571861)
21. Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer.
Masood R; Roy I; Zu S; Hochstim C; Yong KT; Law WC; Ding H; Sinha UK; Prasad PN
Integr Biol (Camb); 2012 Feb; 4(2):132-41. PubMed ID: 22159374
[TBL] [Abstract][Full Text] [Related]
22. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
[TBL] [Abstract][Full Text] [Related]
23. Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities.
Kondo N; Tsukuda M; Taguchi T; Nakazaki K; Sakakibara A; Takahashi H; Toth G; Nishimura G
Cancer Sci; 2011 Sep; 102(9):1717-23. PubMed ID: 21631644
[TBL] [Abstract][Full Text] [Related]
24. WRN translocation from nucleolus to nucleoplasm is regulated by SIRT1 and required for DNA repair and the development of chemoresistance.
Lee SY; Lee H; Kim ES; Park S; Lee J; Ahn B
Mutat Res; 2015 Apr; 774():40-8. PubMed ID: 25801465
[TBL] [Abstract][Full Text] [Related]
25. Role for the Werner syndrome protein in the promotion of tumor cell growth.
Opresko PL; Calvo JP; von Kobbe C
Mech Ageing Dev; 2007; 128(7-8):423-36. PubMed ID: 17624410
[TBL] [Abstract][Full Text] [Related]
26. Association of gene polymorphisms with development of cancer risk or their protective role associated with some mutant alleles.
Nayeemuddin KM; Rafeeq S; Lodhi AK
Indian J Med Res; 2011 Jun; 133(6):577-80. PubMed ID: 21727655
[No Abstract] [Full Text] [Related]
27. Head and neck squamous cell carcinoma targeted chemosensitization.
Figures MR; Wobb J; Araki K; Liu T; Xu L; Zhu H; O'Malley BW; Li D
Otolaryngol Head Neck Surg; 2009 Aug; 141(2):177-83. PubMed ID: 19643248
[TBL] [Abstract][Full Text] [Related]
28. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
Adhim Z; Lin X; Huang W; Morishita N; Nakamura T; Yasui H; Otsuki N; Shigemura K; Fujisawa M; Nibu K; Shirakawa T
Cancer Gene Ther; 2012 Feb; 19(2):144-52. PubMed ID: 22116375
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-28B acts synergistically with cisplatin to suppress the growth of head and neck squamous cell carcinoma.
Yoshimoto K; Kishida T; Nakano H; Matsui M; Shin-Ya M; Shimada T; Nakai S; Imanishi J; Takeuchi M; Hisa Y; Mazda O
J Immunother; 2011 Mar; 34(2):139-48. PubMed ID: 21304406
[TBL] [Abstract][Full Text] [Related]
30. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition.
Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R
Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438
[TBL] [Abstract][Full Text] [Related]
31. A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma.
Saito H; Ando S; Morishita N; Lee KM; Dator D; Dy D; Shigemura K; Adhim Z; Nibu K; Fujisawa M; Shirakawa T
Anticancer Res; 2014 Jul; 34(7):3365-70. PubMed ID: 24982341
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.
Chen WH; Lecaros RL; Tseng YC; Huang L; Hsu YC
Cancer Lett; 2015 Apr; 359(1):65-74. PubMed ID: 25596376
[TBL] [Abstract][Full Text] [Related]
34. Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas.
Bhatia S; Hirsch K; Sharma J; Oweida A; Griego A; Keysar S; Jimeno A; Raben D; Krasnoperov V; Gill PS; Pasquale EB; Wang XJ; Karam SD
Sci Rep; 2016 Dec; 6():38792. PubMed ID: 27941840
[TBL] [Abstract][Full Text] [Related]
35. Bcl-2 targeted-therapy for the treatment of head and neck squamous cell carcinoma.
dos Santos LV; Carvalho AL
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):45-57. PubMed ID: 21110823
[TBL] [Abstract][Full Text] [Related]
36. 5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.
Kerk SA; Finkel KA; Pearson AT; Warner KA; Zhang Z; Nör F; Wagner VP; Vargas PA; Wicha MS; Hurt EM; Hollingsworth RE; Tice DA; Nör JE
Clin Cancer Res; 2017 May; 23(10):2516-2527. PubMed ID: 27780858
[No Abstract] [Full Text] [Related]
37. Estrogen prevents senescence through induction of WRN, Werner syndrome protein.
Lee SJ; Lee SH; Ha NC; Park BJ
Horm Res Paediatr; 2010; 74(1):33-40. PubMed ID: 20395656
[TBL] [Abstract][Full Text] [Related]
38. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
39. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
Roh JL; Park JY; Kim EH; Jang HJ
Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
[TBL] [Abstract][Full Text] [Related]
40. Axon guidance molecule semaphorin3A is a novel tumor suppressor in head and neck squamous cell carcinoma.
Wang Z; Chen J; Zhang W; Zheng Y; Wang Z; Liu L; Wu H; Ye J; Zhang W; Qi B; Wu Y; Song X
Oncotarget; 2016 Feb; 7(5):6048-62. PubMed ID: 26755661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
